# FDA Deploys AI Tool to Accelerate Review Processes

**Source:** Forbes  
**Date:** 2025-06-23  
**URL:** [https://www.forbes.com/topics/artificial-intelligence/?utm_source=openai](https://www.forbes.com/topics/artificial-intelligence/?utm_source=openai)  

## Summary

The U.S. Food and Drug Administration (FDA) has deployed a generative AI tool called ELSA to significantly speed up the review process of medical products. This AI tool has reduced the typical review time from three days to just six minutes, boosting efficiency in regulatory assessments. This innovation marks a substantial improvement in the FDA's review capabilities, potentially accelerating the availability of safe medical products to the public.